Finance

Lists
Q2 2027 earnings
See results
GUFICBIO:NSE
Gufic BioSciences Ltd
₹433.60
+2.69%
(+11.35) 1D
Nov 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GUFICBIO...
Open
₹422.95
High
₹436.00
Low
₹417.55
Mkt. cap
43.41B
Avg. vol.
139.94K
Volume
47.57K
Dividend
0.02%
Quarterly dividend
₹0.02
Ex-dividend date
Aug 28, 2026
P/E ratio
59.21
52-wk high
₹493.95
52-wk low
₹268.00
EPS
₹7.32
Shares outstanding
77.83M
No. of employees
2K
Open
₹422.95
High
₹436.00
Low
₹417.55
Mkt. cap
43.41B
Avg. vol.
139.94K
Volume
47.57K
Dividend
0.02%
Quarterly dividend
₹0.02
Ex-dividend date
Aug 28, 2026
P/E ratio
59.21
52-wk high
₹493.95
52-wk low
₹268.00
EPS
₹7.32
Shares outstanding
77.83M
No. of employees
2K
News stories
From web sources and news partners
About Gufic BioSciences Ltd
CEOJayesh P. Choksi
Employees1.61K
Founded1970
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitegufic.com
Last report
Nov 16, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
2.89B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.31B
2.52B
2.61B
2.89B
Cost of goods sold
1.01B
1.23B
1.15B
1.35B
Cost of revenue
1.01B
1.23B
1.15B
1.35B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
400.89M
432.36M
418.05M
454.29M
Operating expense
1.05B
889.21M
1.07B
1.12B
Total operating expenses
2.06B
2.12B
2.22B
2.48B
Operating income
252.86M
395.66M
389.00M
418.87M
Other non operating income
7.90M
-47.39M
4.58M
-
EBT including unusual items
177.20M
289.51M
300.39M
314.47M
EBT excluding unusual items
177.20M
289.55M
300.39M
314.47M
Income tax expense
52.97M
70.54M
77.27M
79.79M
Effective tax rate
29.89%
24.37%
25.72%
25.37%
Other operating expenses
573.22M
380.37M
574.07M
590.28M
Net income
124.24M
218.97M
223.13M
234.69M
Net profit margin
5.37%
8.70%
8.55%
8.11%
Earnings per share
-
-
-
-
Interest and investment income
-
16.90M
-
-
Interest expense
-83.56M
-79.83M
-93.18M
-104.40M
Net interest expenses
-83.56M
-62.93M
-93.18M
-104.40M
Depreciation and amortization charges
76.92M
76.49M
77.06M
77.32M
EBITDA
286.97M
454.81M
448.16M
496.06M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps